News

PassPort Technologies, Inc. Announces Positive Interim Phase I Results of Zolmitriptan Transdermal Microporation System for the Treatment of Acute Migraine

SAN DIEGO, March 29, 2024 /PRNewswire/ — PassPort Technologies, Inc. (PPTI), based in San Diego, a clinical-stage drug and medical device development company, today announced positive interim results from the Phase 1 (Part A) clinical […]


ADVERTISEMENT — Advertise With Biotech Networks
News

Global Warming Is Influencing Global Timekeeping

A problem is coming for global timekeeping, according to a new paper in the journal Nature by Scripps Institution of Oceanography geophysicist Duncan Agnew, and global warming is influencing when that problem might arrive. Click […]


ADVERTISEMENT — Advertise With Biotech Networks
News

CV Sciences, Inc. Reports Fiscal Year-End 2023 Financial Results

SAN DIEGO, March 28, 2024 /PRNewswire/ — CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent consumer wellness company specializing in hemp extracts and other proven science-backed, natural ingredients and […]

News

Ionis to hold olezarsen Phase 3 data webcast

Webcast scheduled for Monday, April 8 at 10:00 a.m. Eastern Time CARLSBAD, Calif., March 28, 2024 /PRNewswire/ — Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) announced today that it will host a live webcast on Monday, April […]


ADVERTISEMENT — Advertise With Biotech Networks
News

Book Honors Archaeologist’s Storied Career

A peer-reviewed, two-volume book celebrates the career of archaeologist Thomas Levy, a UC San Diego Qualcomm Institute affiliate and recently retired distinguished professor with the Department of Anthropology and Jewish Studies Program. Click here to […]

No Picture
News

Plagiocephaly and Torticollis Awareness Month

New Study Offering Free Plagiocephaly Treatment (an alternative to helmet therapy) in San Diego, California! SAN DIEGO, March 27, 2024 /PRNewswire/ — The Osteopathic Center for Children & Osteopathy’s Promise to Children is now looking […]


ADVERTISEMENT — Advertise With Biotech Networks
News

Kintara Therapeutics Announces Expansion of REM-001 Clinical Study to Include Patients on Pembrolizumab

SAN DIEGO, March 27, 2024 /PRNewswire/ — Kintara Therapeutics, Inc. (Nasdaq: KTRA) (“Kintara” or the “Company”), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced the expansion of the […]

No Picture
News

MediciNova Receives a Notice of Allowance for a New Patent Covering MN-166 (ibudilast) for the Treatment of Macular Injury in Japan

LA JOLLA, Calif., March 26, 2024 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today announced […]


ADVERTISEMENT — Advertise With Biotech Networks

ADVERTISEMENT — Advertise With Biotech Networks
News

Lawsuit Notice: Investors who lost money with BioVie Inc. (NASDAQ: BIVI) shares should contact the Shareholders Foundation

SAN DIEGO, March 26, 2024 /PRNewswire/ — The Shareholders Foundation, Inc. announced that a lawsuit is pending for certain investors in BioVie Inc. (NASDAQ: BIVI) shares. Investors, who purchased shares of BioVie Inc. (NASDAQ: BIVI) […]

No Picture
News

New Data Show ClearNote Health’s Epigenomic Platform Provides a Novel Tissue-Free, Liquid Biopsy-Based Approach to Identify Potential Predictive Biomarker Candidates to Radioligand Therapy Response in Patients With Pancreatic Neuroendocrine Tumors

SAN DIEGO–(BUSINESS WIRE)–ClearNote® Health, a company on a mission to enable longer lives for people with cancer through earlier detection, today announced results from a collaboration study with Novartis and the Norwegian Biobank assessing plasma-based […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Function Oncology Announces Innovative Precision Medicine Partnership with Volastra Therapeutics

SAN DIEGO–(BUSINESS WIRE)– #CRISPR–Function Oncology, a company transforming the operating system of precision medicine with CRISPR-powered platform technology, today announced an innovative research and development partnership with Volastra Therapeutics, a company pioneering novel approaches to […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Equillium Reports on Fourth Quarter and Full Year 2023 Financial Results and Corporate and Clinical Highlights

LA JOLLA, Calif.–(BUSINESS WIRE)—- $EQ–Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging a deep understanding of immunobiology to develop novel therapeutics to treat severe autoimmune and inflammatory disorders, today announced financial results for the […]


ADVERTISEMENT — Advertise With Biotech Networks
News

Positive olezarsen Phase 3 data in familial chylomicronemia syndrome to be presented at 2024 American College of Cardiology (ACC) annual meeting

– First presentation of pivotal results showing significant reduction in triglycerides and substantial reduction in acute pancreatitis events in patients with rare, life-threatening disease, for which there are no approved treatment options in U.S. – […]

News

National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) Hosts Inaugural U.S. Biopharma Workforce Partnership Conference April 17-18, 2024 in Boston, Massachusetts

Biopharma Hiring Professionals Invited to Convene in Boston to Forge Valuable Connections and Learn About Improving US Talent Pipelines NEWARK, Del., and BOSTON, Mass. March 22, 2024 — On April 17-18, the National Institute for […]